US Patent 7494660 HCV NS3-NS4A protease resistance mutants
Patent 7494660 was granted and assigned to Vertex Pharmaceuticals on February, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 27, 2004
0
Date of Patent
February 24, 2009
0
Patent Application Number
10974558
0
Patent Inventor Names
Chao Lin
0
Kai Lin
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7494660 HCV NS3-NS4A protease resistance mutants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.